Comparative effectiveness research is necessary so physicians, researchers, and patients, know how different drugs stack up against each other, says Forbes' Avik Roy on The Apothecary blog. While the private sector spends billions of dollars a year on such research, Roy says that NIH also has a role to play in funding.